Ishimaru, S., Gueguen, G., Karol, S., Bautista, F., Mijnders-Remers, M., Sluijs, J., Anderson, J., Lukin, J., Collins, A., Tinteren, H. V., Galderisi, F., Dhalla, M., Onishi, M., Scherer, F., Unnebrink, K., Tomizawa, D., Reinhardt, D., Locatelli, F., Rubio-San-Simon, A., Nichols, G., Cooper, T., Tasian, S., Zwaan, C. (2025). ITCC-101/APAL2020D: A randomized Phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamycin with or without venetoclax in children with relapsed Acute Myeloid Leukemia. Blood. https://doi.org/10.1182/blood-2025-1656